UEMS survey highlights accessibility disparities, inconsistent policies for anti-VEGF treatment across Europe

A survey conducted across the 28 EU countries and Switzerland by the European Union of Medical Specialists highlighted a diverse and uneven scenario of anti-VEGF treatment in Europe in terms of numbers, prices, rules and policies. “These results paint a clear picture, and this is in itself an important achievement. From here, we know what has to be addressed,” Marko Hawlina, MD, PhD, vice president of the ophthalmology section of the European Union of Medical Specialists (UEMS), said.